Dasigao, Almera .

HRN: 05-09-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
CEFUROXIME 1.5GM (VIAL)
11/29/2024
11/29/2024
IV
1.5 G
PTOR
Pre-op Prophylaxis
Waiting Final Action 
11/29/2024
CEFUROXIME 750MG (VIAL)
11/29/2024
11/30/2024
IV
750mg
Q8 X 3 Doses
Post OP Prophylaxis
Waiting Final Action 
11/29/2024
CEFUROXIME 500MG (TAB)
11/30/2024
12/07/2024
PO
500mg Tab
BID
Post OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: